Hans-Jürgen Hurtz

Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma

Wolfram Pönisch, Barbara Moll, Simone Heyn et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

Hans‐Joachim Stemmler, Dorit DiGioia, Werner Freier et al. · British Journal of Cancer · 2011 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project

Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler et al. · Breast Cancer Research and Treatment · 2017 · 22 citations · Full text

Medicine, Oncology, Breast Oncology +16

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis

Christian M. Kurbacher, Thomas Fietz, Ingo Diel et al. · Oncology Research and Treatment · 2015 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study

Peter J. Goebell, Lothar Müller, Hans-Jürgen Hurtz et al. · Clinical Genitourinary Cancer · 2015 · 10 citations

Medicine, Nephrology, Oncology +12